With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Source link
India's cheap weight-loss drugs could reshape global obesity fight
Recommended
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!